Cargando…
Development and Validation of a Western Blot Method to Quantify Mini-Dystrophin in Human Skeletal Muscle Biopsies
Duchenne muscular dystrophy (DMD) is a degenerative muscular disease affecting roughly one in 5000 males at birth. The disease is often caused by inherited X-linked recessive pathogenic variants in the dystrophin gene, but may also arise from de novo mutations. Disease-causing variants include nonse...
Autores principales: | Soderstrom, Catherine I., Larsen, Jennifer, Owen, Carolina, Gifondorwa, David, Beidler, David, Yong, Florence H., Conrad, Patricia, Neubert, Hendrik, Moore, Steven A., Hassanein, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034579/ https://www.ncbi.nlm.nih.gov/pubmed/36539515 http://dx.doi.org/10.1208/s12248-022-00776-0 |
Ejemplares similares
-
Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy
por: Farrokhi, Vahid, et al.
Publicado: (2021) -
Quantifying western blots: none more black
por: Bell, Graham
Publicado: (2016) -
Effects of Mini-Dystrophin on Dystrophin-Deficient, Human Skeletal Muscle-Derived Cells
por: Meng, Jinhong, et al.
Publicado: (2020) -
Single-cell western blotting
por: Hughes, Alex J., et al.
Publicado: (2014) -
Characterization of 65 Epitope-Specific Dystrophin Monoclonal Antibodies in Canine and Murine Models of Duchenne Muscular Dystrophy by Immunostaining and Western Blot
por: Kodippili, Kasun, et al.
Publicado: (2014)